Clinical Trial Update: Evaluation of a New Cardiac Pacemaker [NA]

View source ↗

Summary

Clinical trial update on a new Nanostim cardiac pacemaker for patients with atrial fibrillation and conduction-block conditions; the status and phase are not sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Block
• Sinus Bradycardia
• Syncope

Snippet

Sponsor: Nanostim, Inc. | Conditions: Atrial Fibrillation With 2 or 3° AV or Bifascicular Bundle Branch (BBB) Block, Normal Sinus Rhythm With 2 or 3° AV or BBB Block | NA | Status: UNKNOWN